Literature DB >> 19390331

Detection of hepatitis C mutants with natural resistance to NS3/4A protease inhibitors in HIV/HCV-coinfected individuals treated with antiretroviral therapy.

Giulia Morsica, Sabrina Bagaglio, Caterina Uberti-Foppa, Laura Galli, Adriano Lazzarin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19390331     DOI： 10.1097/QAI.0b013e3181a02fda

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  4 in total

1.  HCV NS3 naturally occurring variants in HIV/HCV coinfected DAA-naïve patients: consideration for HCV genotyping resistance testing.

Authors:  T Ruggiero; E Burdino; A Calcagno; S Bonora; L Boglione; G Di Perri; V Ghisetti
Journal:  Infection       Date:  2016-08-13       Impact factor: 3.553

2.  Hepatitis C virus NS3 mutations in haemophiliacs.

Authors:  M V Lin; A N Charlton; S D Rouster; P J Zamor; K E Sherman
Journal:  Haemophilia       Date:  2014-04-03       Impact factor: 4.287

3.  Naturally occurring mutations to HCV protease inhibitors in treatment-naïve patients.

Authors:  Stefania Paolucci; Loretta Fiorina; Antonio Piralla; Roberto Gulminetti; Stefano Novati; Giorgio Barbarini; Paolo Sacchi; Marta Gatti; Luca Dossena; Fausto Baldanti
Journal:  Virol J       Date:  2012-10-24       Impact factor: 4.099

4.  Natural Polymorphisms Conferring Resistance to HCV Protease and Polymerase Inhibitors in Treatment-Naïve HIV/HCV Co-Infected Patients in China.

Authors:  Kali Zhou; Zhiwei Liang; Charles Wang; Fengyu Hu; Chuanyi Ning; Yun Lan; Xiaoping Tang; Joseph D Tucker; Weiping Cai
Journal:  PLoS One       Date:  2016-06-24       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.